Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report

Conclusion As far as we know this is the first report on pazopanib induced TLS. We advise further research in order to identify the exact mechanism behind TKI-induced TLS and the patients at risk of developing TLS.

http://link.springer.com/10.1007/s10637-018-0576-y

Source: Investigational New Drugs - February 20, 2018 Category: Drugs & Pharmacology Source Type: research